Heidelberg Pharma AG (HPHA)

PRESS RELEASE

published on 11/06/2024 at 10:02, 5 months 27 days ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting
BRIEF

published on 10/24/2024 at 11:08, 6 months 10 days ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
BRIEF

published on 10/24/2024 at 11:08, 6 months 10 days ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201
PRESS RELEASE

published on 10/24/2024 at 11:03, 6 months 10 days ago

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
Heidelberg Pharma to present ADC candidates at scientific and financial conferences in November 2024. Updates on Amanitin-based HDP-101 and Exatecan-based HDP-201. Key targets and conference details

Heidelberg Pharma Scientific Conferences ADC Candidates Amanitin Exatecan
BRIEF

published on 10/10/2024 at 07:11, 6 months 24 days ago

Rapport intermédiaire de Heidelberg Pharma AG pour les neuf premiers mois de 2024

Rapport Financier Heidelberg Pharma Résultats Cliniques Essai Du HDP-101 Vente De Redevances
BRIEF

published on 10/10/2024 at 07:11, 6 months 24 days ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
PRESS RELEASE

published on 10/10/2024 at 07:06, 6 months 24 days ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 7 months 2 days ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC
BRIEF

published on 10/01/2024 at 17:34, 7 months 2 days ago

Heidelberg Pharma présente des données cliniques prometteuses pour le candidat ADC phare HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple ADC Données Cliniques
PRESS RELEASE

published on 10/01/2024 at 17:29, 7 months 2 days ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission

Published on 05/03/2025 at 03:40, 19 hours 29 minutes ago

Snipp Interactive Announces Delay in Filing Audited Fiscal 2024 Financial Statements
Published on 05/03/2025 at 03:00, 20 hours 9 minutes ago

Vision Marine Technologies Inc. Announces Postponement of Annual Meeting of Shareholders
Published on 05/03/2025 at 02:06, 21 hours 3 minutes ago

Battery X Metals Achieves Pivotal Milestone with Delivery of Next-Generation Lithium-Ion Battery Rebalancing Machine and Announces Exclusive Live Reveal Event
Published on 05/02/2025 at 23:30, 23 hours 39 minutes ago

RE Royalties Announces Fiscal 2024 Year End Results and Highlights
Published on 05/02/2025 at 15:00, 1 day 8 hours ago

Newsmax #1 in Cable News for Key Demo Ratings Growth

View all ACCESSWIRE

Published on 05/03/2025 at 07:57, 15 hours 12 minutes ago

EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31,2024
Published on 05/02/2025 at 19:00, 1 day 4 hours ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 05/02/2025 at 18:55, 1 day 4 hours ago

Avolta's Q1 Trading Update Invitation
Published on 05/02/2025 at 18:41, 1 day 4 hours ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/02/2025 at 18:30, 1 day 4 hours ago

Avolta's Full Year 2024 Results Invitation

View all EQS

Published on 05/02/2025 at 20:40, 1 day 2 hours ago

Rapport Financier Annuel 2024
Published on 05/02/2025 at 17:35, 1 day 5 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 04/30/2025 at 20:31, 3 days 2 hours ago

COMMUNIQUE DE PRESSE - RESULTATS 2024
Published on 04/30/2025 at 19:14, 3 days 3 hours ago

Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 3 days 3 hours ago

Solocal - Press Release - Filing of 2024 URD

View all LES ECHOS COMFI WIRE

News